Request Deal Involvement
Gurnet Point Capital and Novo completed the acquisition of Paratek Pharmaceuticals for $462m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
financial advisors
Lazard
legal advisors to debt providers
Sullivan & Cromwell
debt providers
Oaktree Capital Management
pr advisors
H/Advisors Abernathy
pr advisors
FGS Global
financial advisors
Moelis & Co
legal advisors
Ropes & Gray
legal advisors to financial advisors
Freshfields Bruckhaus Deringer
legal advisors
Goodwin Procter
or
Principals
bidder
GURNET POINT CAPITAL LIMITED
target
PARATEK PHARMACEUTICALS
bidder
NOVO HOLDINGS A/S
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite